1. Home
  2. HHH vs HAE Comparison

HHH vs HAE Comparison

Compare HHH & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HHH

Howard Hughes Holdings Inc.

HOLD

Current Price

$70.06

Market Cap

4.1B

Sector

Real Estate

ML Signal

HOLD

HAE

Haemonetics Corporation

HOLD

Current Price

$118.66

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HHH
HAE
Founded
2010
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.8B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
HHH
HAE
Price
$70.06
$118.66
Analyst Decision
Buy
Buy
Analyst Count
3
11
Target Price
$84.00
★ $124.50
AVG Volume (30 Days)
★ 680.1K
607.7K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.82
0.72
Revenue
★ $1,474,892,000.00
$910,373,000.00
Revenue This Year
$70.68
$6.21
Revenue Next Year
N/A
$5.54
P/E Ratio
★ $24.68
$162.15
Revenue Growth
N/A
★ N/A
52 Week Low
$60.09
$48.98
52 Week High
$91.07
$123.77

Technical Indicators

Market Signals
Indicator
HHH
HAE
Relative Strength Index (RSI) 52.54 64.22
Support Level $61.79 $100.92
Resistance Level $74.76 $123.77
Average True Range (ATR) 2.09 3.68
MACD -0.43 -0.20
Stochastic Oscillator 47.15 77.24

Price Performance

Historical Comparison
HHH
HAE

About HHH Howard Hughes Holdings Inc.

Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: